The Changing Landscape of Neonatal Diabetes Mellitus in Italy Between 2003 and 2022

Abstract

Context

In the last decade the Sanger method of DNA sequencing has been replaced by next-generation sequencing (NGS). NGS is valuable in conditions characterized by high genetic heterogeneity such as neonatal diabetes mellitus (NDM).

Objective

To compare results of genetic analysis of patients with NDM and congenital severe insulin resistance (c.SIR) identified in Italy in 2003-2012 (Sanger) vs 2013-2022 (NGS).

Methods

We reviewed clinical and genetic records of 104 cases with diabetes onset before 6 months of age (NDM + c.SIR) of the Italian dataset.

Results

Fifty-five patients (50 NDM + 5 c.SIR) were identified during 2003-2012 and 49 (46 NDM + 3 c.SIR) in 2013-2022. Twenty-year incidence was 1:103 340 (NDM) and 1:1 240 082 (c.SIR) live births. Frequent NDM/c.SIR genetic defects (KCNJ11, INS, ABCC8, 6q24, INSR) were detected in 41 and 34 probands during 2003-2012 and 2013-2022, respectively. We identified a pathogenic variant in rare genes in a single proband (GATA4) (1/42 or 2.4%) during 2003-2012 and in 8 infants (RFX6, PDX1, GATA6, HNF1B, FOXP3, IL2RA, LRBA, BSCL2) during 2013-2022 (8/42 or 19%, P = .034 vs 2003-2012). Notably, among rare genes 5 were recessive. Swift and accurate genetic diagnosis led to appropriate treatment: patients with autoimmune NDM (FOXP3, IL2RA, LRBA) were subjected to bone marrow transplant; patients with pancreas agenesis/hypoplasia (RFX6, PDX1) were supplemented with pancreatic enzymes, and the individual with lipodystrophy caused by BSCL2 was started on metreleptin.

Conclusion

NGS substantially improved diagnosis and precision therapy of monogenic forms of neonatal diabetes and c.SIR in Italy.

Overview publication

TitleThe Changing Landscape of Neonatal Diabetes Mellitus in Italy Between 2003 and 2022
DateAugust 13th, 2024
Issue nameThe Journal of Clinical Endocrinology & Metabolism
Issue numberv109.9 p2349-2357
DOI10.1210/clinem/dgae095
AuthorsRapini N, Delvecchio M, Mucciolo M, Ruta R, Rabbone I, Cherubini V, Zucchini S, Cianfarani S, Prandi E, Schiaffini R, Bizzarri C, Piccini B, Maltoni G, Predieri B, Minuto N, Di Paola R, Giordano M, Tinto N, Grasso V, Russo L, Tiberi V, Scaramuzza A, Frontino G, Maggio MC, Musolino G, Piccinno E, Tinti D, Carrera P, Mozzillo E, Cappa M, Iafusco D, Bonfanti R, Novelli A, Barbetti F, Beccaria L, Candia F, Cauvin V, Cardani R, Cardella F, Favia A, Gallo F, Garzia P, Ghirri P, Innaurato S, Iughetti L, Laforgia N, Lo Presti D, Marsciani A, Meschi F, Panzeca R, Pasquino B, Pesavento R, Pezzino G, Reinstadler P, Ripoli C, Savastio S, Timpanaro T, Tumini S & Vento G
InfoDiabetes Study Group of Italian Society for Pediatric Endocrinology and Diabetes (ISPED)
MTGsMTG3
Read Read publication